Interestingly, distinct differences exist between breast cancer subtype recurrence rates and correlate well with the hormone receptor levels in breast cancer [2,3,4], demonstrating that subtype is important and should be taken into account for patient recurrence rates. This evidence concerns the gene NR4A1 and breast cancer.